PRKCD
Protein kinase C delta type
Also known as: KPCD_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q05655
- Gene
- PRKCD
- Ensembl
- ENSG00000163932
- Chromosome
- 3
- Canonical length
- 676 aa
- Protein class
- Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins
- Subcellular location
- Endoplasmic reticulum,Golgi apparatus,Cytosol
OverviewNCBI Gene
The protein encoded by this gene is a member of the protein kinase C family of serine- and threonine-specific protein kinases. The encoded protein is activated by diacylglycerol and is both a tumor suppressor and a positive regulator of cell cycle progression. Also, this protein can positively or negatively regulate apoptosis. Defects in this gene are a cause of autoimmune lymphoproliferative syndrome. [provided by RefSeq, Aug 2017]
Canonical amino-acid sequenceUniProt
676 residues, UniProt reviewed canonical sequence.
>Q05655|PRKCD
1 MAPFLRIAFN SYELGSLQAE DEANQPFCAV KMKEALSTER GKTLVQKKPT MYPEWKSTFD
61 AHIYEGRVIQ IVLMRAAEEP VSEVTVGVSV LAERCKKNNG KAEFWLDLQP QAKVLMSVQY
121 FLEDVDCKQS MRSEDEAKFP TMNRRGAIKQ AKIHYIKNHE FIATFFGQPT FCSVCKDFVW
181 GLNKQGYKCR QCNAAIHKKC IDKIIGRCTG TAANSRDTIF QKERFNIDMP HRFKVHNYMS
241 PTFCDHCGSL LWGLVKQGLK CEDCGMNVHH KCREKVANLC GINQKLLAEA LNQVTQRASR
301 RSDSASSEPV GIYQGFEKKT GVAGEDMQDN SGTYGKIWEG SSKCNINNFI FHKVLGKGSF
361 GKVLLGELKG RGEYFAIKAL KKDVVLIDDD VECTMVEKRV LTLAAENPFL THLICTFQTK
421 DHLFFVMEFL NGGDLMYHIQ DKGRFELYRA TFYAAEIMCG LQFLHSKGII YRDLKLDNVL
481 LDRDGHIKIA DFGMCKENIF GESRASTFCG TPDYIAPEIL QGLKYTFSVD WWSFGVLLYE
541 MLIGQSPFHG DDEDELFESI RVDTPHYPRW ITKESKDILE KLFEREPTKR LGVTGNIKIH
601 PFFKTINWTL LEKRRLEPPF RPKVKSPRDY SNFDQEFLNE KARLSYSDKN LIDSMDQSAF
661 AGFSFVNPKF EHLLEDLocalizationUniProt · AlphaFold · HPA
Whether an antibody against PRKCD can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.3
- Highest tissue expression
- 71 nTPM
Expression across tissuesHPA
Tissue
- bone marrow: 71 nTPM
- tonsil: 53 nTPM
- stomach: 52 nTPM
- adrenal gland: 50 nTPM
- spleen: 46 nTPM
- small intestine: 46 nTPM
Single-cell type
- neutrophils: 357 nCPM
- platelets: 143 nCPM
- late spermatids: 140 nCPM
- esophageal apical cells: 117 nCPM
- neutrophil progenitors: 106 nCPM
- enterocytes: 106 nCPM
Immune cell
- classical monocyte: 72 nTPM
- intermediate monocyte: 70 nTPM
- myeloid DC: 55 nTPM
- basophil: 50 nTPM
- neutrophil: 48 nTPM
- eosinophil: 48 nTPM
Brain region
- cerebral cortex: 28 nTPM
- hypothalamus: 27 nTPM
- white matter: 26 nTPM
- basal ganglia: 25 nTPM
- amygdala: 24 nTPM
- medulla oblongata: 23 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about PRKCD.
Disease | AllUniProt
Conditions PRKCD is implicated in, by any mechanism.
- Autoimmune lymphoproliferative syndrome 3 (ALPS3) MIM:615559
Disease | GeneticClinVar
19 pathogenic / likely-pathogenic of 649 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Autoimmune lymphoproliferative syndrome, type III caused by mutation in PRKCD
- Lymphoma
Disease | ImmuneIEDB
Conditions an epitope on PRKCD was assayed in.
- rheumatoid arthritis B cell
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.17
- gnomAD pLI
- 1
- gnomAD missense Z
- 3.11
- DepMap mean gene effect
- -0.07
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- apoptotic process
- B cell proliferation
- cell chemotaxis
- cellular response to angiotensin
- cellular response to fatty acid
- cellular response to hydrogen peroxide
- cellular response to hydroperoxide
- cellular response to UV
- cellular senescence
- defense response to bacterium
- DNA damage response
- Fc-gamma receptor signaling pathway involved in phagocytosis
- immunoglobulin mediated immune response
- intracellular signal transduction
- intrinsic apoptotic signaling pathway in response to oxidative stress
- negative regulation of actin filament polymerization
- negative regulation of filopodium assembly
- negative regulation of glial cell apoptotic process
- negative regulation of inflammatory response
- negative regulation of insulin receptor signaling pathway
- negative regulation of MAPK cascade
- negative regulation of platelet aggregation
- neutrophil activation
- peptidyl-serine phosphorylation
- peptidyl-threonine phosphorylation
- phospholipase C/protein kinase C signal transduction
- positive regulation of apoptotic signaling pathway
- positive regulation of ceramide biosynthetic process
- positive regulation of DNA repair
- positive regulation of protein import into nucleus
- positive regulation of sphingomyelin catabolic process
- positive regulation of superoxide anion generation
- protein kinase C signaling
- protein phosphorylation
- protein stabilization
- regulation of actin cytoskeleton organization
- regulation of ceramide biosynthetic process
- regulation of mRNA stability
- signal transduction
- termination of signal transduction
- positive regulation of glucosylceramide catabolic process
- positive regulation of phospholipid scramblase activity
Molecular functions
- ATP binding
- diacylglycerol-dependent serine/threonine kinase activity
- diacylglycerol-dependent, calcium-independent serine/threonine kinase activity
- enzyme activator activity
- enzyme binding
- insulin receptor substrate binding
- non-membrane spanning protein tyrosine kinase activity
- protein kinase activity
- protein kinase binding
- protein serine kinase activity
- protein serine/threonine kinase activity
- protein tyrosine kinase activator activity
- zinc ion binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
- C2 domain
- Protein kinase domain
- AGC-kinase, C-terminal
- Protein kinase C-like, phorbol ester/diacylglycerol-binding domain
- Serine/threonine-protein kinase, active site
- Protein kinase-like domain superfamily
- Protein kinase C, delta/epsilon/eta/theta types
- Protein kinase, ATP binding site
- Protein kinase, C-terminal
- Diacylglycerol/phorbol-ester binding
- C2 domain superfamily
- C1-like domain superfamily
- Protein kinase domain
- Phorbol esters/diacylglycerol binding domain (C1 domain)
- Protein kinase C terminal domain
- Protein kinase C delta/epsilon/eta/theta, C2 domain
- Protein kinase C, delta
- Novel protein kinase C delta, catalytic domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of PRKCD in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads PRKCD as an antibody target. Whether an autoantibody or antibody against PRKCD could matter depends on whether native PRKCD is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
PRKCD is annotated at the cell surface, where native PRKCD is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Source-annotated serology context
The source annotations explicitly mention antibody, autoantibody, autoantigen, or autoimmune context. This is biological context, not study-specific reactivity.
- Defects in this gene are a cause of autoimmune lymphoproliferative syndrome.
Loading the interactive Seroatlas protein explorer...